BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kutryb-Zajac B, Mierzejewska P, Slominska EM, Smolenski RT. Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases. Molecules 2020;25:E4652. [PMID: 33053898 DOI: 10.3390/molecules25204652] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Gessler S, Guthmann C, Schuler V, Lilienkamp M, Walz G, Yakulov TA. Control of Directed Cell Migration after Tubular Cell Injury by Nucleotide Signaling. Int J Mol Sci 2022;23:7870. [PMID: 35887219 DOI: 10.3390/ijms23147870] [Reference Citation Analysis]
2 Schrader J. Ectonucleotidases as bridge between the ATP and adenosine world: reflections on Geoffrey Burnstock. Purinergic Signal 2022. [PMID: 35522386 DOI: 10.1007/s11302-022-09862-6] [Reference Citation Analysis]
3 Ademosun AO, Popoola TV, Oboh G, Fasakin OW. Parquetina nigrescens and Spondias mombin protects against neurochemical alterations in the scopolamine model of cognitive dysfunction. J Food Biochem 2022;:e14213. [PMID: 35475510 DOI: 10.1111/jfbc.14213] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jędrzejewska A, Kutryb-Zając B, Król O, Harasim G, Frańczak M, Jabłońska P, Słomińska E, Smoleński RT. The decreased serum activity of cytosolic 5'-nucleotidase IA as a potential marker of breast cancer-associated muscle inflammation. Nucleosides Nucleotides Nucleic Acids 2022;41:273-84. [PMID: 34814800 DOI: 10.1080/15257770.2021.2007396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.04.013] [Reference Citation Analysis]
6 El-Said KS, Atta A, Mobasher MA, Germoush MO, Mohamed TM, Salem MM. Quercetin mitigates rheumatoid arthritis by inhibiting adenosine deaminase in rats. Mol Med 2022;28:24. [PMID: 35193490 DOI: 10.1186/s10020-022-00432-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lu CF, Liu WS, Ge XQ, Xu F, Su JB, Wang XQ, Wang Y. The association between serum adenosine deaminase levels and Graves' disease. Endocr Connect 2021;10:1227-33. [PMID: 34473081 DOI: 10.1530/EC-21-0344] [Reference Citation Analysis]
8 Bakaryan A, Karapetyan L, Hakobyan N, Camaioni E, Mardanyan S, Antonyan A. Adenosine deaminase - A target for new piperazine derivatives. Biophys Chem 2021;277:106658. [PMID: 34333397 DOI: 10.1016/j.bpc.2021.106658] [Reference Citation Analysis]
9 Matthews RP, Jackson Rudd D, Fillgrove KL, Zhang S, Tomek C, Stoch SA, Iwamoto M. A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV. Clin Drug Investig 2021;41:629-38. [PMID: 34151413 DOI: 10.1007/s40261-021-01046-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tomczyk M, Glaser T, Slominska EM, Ulrich H, Smolenski RT. Purine Nucleotides Metabolism and Signaling in Huntington's Disease: Search for a Target for Novel Therapies. Int J Mol Sci 2021;22:6545. [PMID: 34207177 DOI: 10.3390/ijms22126545] [Reference Citation Analysis]
11 Zuccarini M, Giuliani P, Caciagli F, Ciccarelli R, Di Iorio P. In Search of a Role for Extracellular Purine Enzymes in Bone Function. Biomolecules 2021;11:679. [PMID: 33946568 DOI: 10.3390/biom11050679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]